CorVel Corporation's stock surged 5.06% during intraday trading on Wednesday, following the release of its fourth-quarter fiscal 2026 financial results.
The healthcare cost management firm reported earnings per share of $0.61 for the quarter ended March 31, 2026, representing a 20% increase compared to $0.51 in the same quarter of the prior year. Revenue grew 7% to $249 million from $232 million year-over-year. The company also reported a 9% increase in gross profit to $63 million and exited the quarter with a strong cash position of $233 million with no borrowings.
CorVel's CERIS health division is benefiting from the healthcare industry's shift toward proactive payment accuracy and cost management, with strong demand for its integrated prepay and post-pay platform. The company highlighted multiple large payer sales with enterprise-scale implementations that provide increased revenue visibility. Ongoing investments in AI, automation, telemedicine, and cybersecurity are expected to support margins and scalability while improving operational efficiency and claim outcomes.